Takeda Drops Suit Over Apotex's Actos ANDA

Law360, New York (April 14, 2011, 2:56 PM EDT) -- A Florida federal judge on Wednesday approved Takeda Pharmaceutical Co. Ltd.'s request to drop a patent infringement suit over Apotex Corp.'s efforts to manufacture a generic version of diabetes medication Actos.

Judge Ursula Ungaro of the U.S. District Court for the Southern District of Florida entered an order dismissing the case without prejudice, based on Takeda's April 8 notice of voluntary dismissal.

Takeda's reason for requesting the dismissal of this case, which the drugmaker filed on March 22, was not revealed, but court records show that...
To view the full article, register now.